alexa Implementation Of Pharmacogenetics In Patient Care
ISSN: 2153-0645

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics
November 03-05, 2014 Embassy Suites Las Vegas, USA

Piatkov Irina
Accepted Abstracts: J Pharmacogenomics Pharmacoproteomics
DOI: 10.4172/2153-0645.S1.004
Interactions between substances metabolised through the same metabolic pathway and variations in enzyme activity should obviously be considered in drug response interpretation. However, despite the accumulation of pharmacogenetic data, the medical application of genotyping is still a subject of debate. One of the reasons is the fact that phenotype characteristics of pharmacogenetics testing are confusing and sometimes, in our opinion, are used in inappropriate ways. Biomedical laboratories provide a variety of pharmacogenetics tests. During the last few years drug manufacturers are placing a new warning into the drug?s prescribing information. This warning cautions medical practitioners of the reduced effectiveness of drugs in patients who are poor metabolisers. However, a heterozygote genotype, which is usually considered as an intermediate metaboliser, with some prescribed drug combinations can also create an ?organic? poor metaboliser. It causes confusion for clinical practitioners and consequently adds to the uncertainty in the clinical application of pharmacogenetics. Our data also demonstrates that the coincidence of multiple loss-of-function heterozygote CYPs polymorphisms producing diminished enzyme activity is rare in any population. Their significance is important though, as it dramatically alters patients metabolising capacity and produces a poor metaboliser phenotype which often results in severe effects arising from the toxicity. As per the latest scientific development, it is undeniable that pharmacogenetics testing in combination with other parameters will help to avoid adverse reactions by providing information about an individual?s drug metabolising capacity, thereby identifying the patients for whom a drug would be safe and also potentially lowering overall healthcare costs. However, precise definitions of phenotype and genotype characteristics are needed to avoid confusion in medical practice. The phenotype and genotype terminology in pharmacogenetics testing interpretation will be discussed. The following will be included in the presentation: Data from our previous projects; data from our laboratory testings and patient individual cases.
Irina Piatkov, PhD, is a Senior Hospital Scientist in Charge of the Blacktown Molecular Research Laboratory at the University of Western Sydney Clinical School and Research Centre, Blacktown Hospital, Western Sydney Local Health District. The laboratory supports research and provides tests in the area of personalised medicine, mostly in pharmacogenetics. As an interdisciplinary centre for scientific research and teaching, it is involved in projects for different hospital departments. She has received her PhD in1986 and started her scientific career in the former USSR. Since that time, she has been working in diagnostic, teaching and research projects in clinical biochemistry and molecular genetics in USSR, Canada and Australia.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version